After two add-on deals in the last three months, Zelis Healthcare, backed by Parthenon Capital and Bain Capital, sees larger M&A opportunities, CEO Amanda Eisel tells Axios.
Why it matters: Zelis has primarily pursued add-ons since it merged with RedCard in 2019 with a $5.7 billion valuation. A large-cap deal by Zelis would throw some fuel on an otherwise tepid M&A market.
